Cargando…
An Observational Cohort Study of the 2-Month Use of Regional Citrate Anticoagulation in Maintenance Hemodialysis Patients with Cerebral Hemorrhage
BACKGROUND: Regional citrate anticoagulation (RCA) is a recommended anticoagulation alternative for patients at high risk of bleeding while undergoing intermittent hemodialysis. Previous reports implied the risk of citrate application on bone metabolism. It is unclear whether long-term use of RCA is...
Autores principales: | Bi, Xiao, Zhang, Qi, Zhuang, Feng, Lu, Wei, Wang, Yingdeng, Ding, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056873/ https://www.ncbi.nlm.nih.gov/pubmed/33859156 http://dx.doi.org/10.12659/MSM.930513 |
Ejemplares similares
-
Regional Citrate Anticoagulation for Intermittent Hemodialysis in Dogs
por: Francey, T., et al.
Publicado: (2017) -
Regional citrate anticoagulation in high-volume continuous venovenous hemodialysis
por: Kalb, R, et al.
Publicado: (2011) -
Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study
por: Slowinski, Torsten, et al.
Publicado: (2015) -
Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study
por: Schultheiß, Caroline, et al.
Publicado: (2012) -
Regional citrate anticoagulation for intermittent hemodialysis in the intensive care: what is the optimal setup?
por: Gubensek, Jakob, et al.
Publicado: (2021)